Skip to content
The Colorado Natural Medicine Health Act Tracker and Bulletin are now live.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Colorado Natural Medicine Advisory Bulletin

      Everything you need to know about implementing the NMHA in Colorado.

      Read the Latest

      News & Press Releases

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Ibogaine Patents
      Ibogaine Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Law Trackers

      Mapping psychedelic drug policy reform across the United States and worldwide.

      Worldwide Tracker
      U.S. Tracker
      Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

  • Post published:March 30, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

  • Post published:March 2, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

  • Post published:February 17, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

  • Post published:February 4, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Psyched Wellness Upsizes Previously Announced Bought Deal Offering

  • Post published:January 25, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

  • Post published:January 21, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Announces New OTCQB Ticker: PSYCF

Psyched Wellness Announces New OTCQB Ticker: PSYCF

  • Post published:January 19, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

  • Post published:January 14, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol

  • Post published:January 6, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

  • Post published:December 28, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.